News

US sues Dr. Reddy, Glenmark, Sun Pharma for price-fixing

drugs

US authorities on alleged price cartelisation by Indian generic drugmakers, have named five pharmaceutical companies including Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceuticals and Zydus Cadila Pharmaceuticals  in a lawsuit for artificially inflating generic drug price in the US.

drugs

These drug makers are facing an anti-trust probe for price-fixing and could face criminal charges and penalties if found guilty. The lawsuit specifically mentions names of two top pharma executives, MD of Emcure, Satish Mehta and Executive Director of Mylan NV, Rajiv Malik.

This comes as another challenge to the Indian pharmas who are already facing stricter regulations from USFDA while trying to expand their market share in the US generic space. It is also expected that the investigators would expand their probe into other generic companies and their executives.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Most Popular

To Top